378 related articles for article (PubMed ID: 18202831)
1. BCRP/ABCG2 in the placenta: expression, function and regulation.
Mao Q
Pharm Res; 2008 Jun; 25(6):1244-55. PubMed ID: 18202831
[TBL] [Abstract][Full Text] [Related]
2. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
Han LW; Gao C; Mao Q
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
[TBL] [Abstract][Full Text] [Related]
3. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
Hahnova-Cygalova L; Ceckova M; Staud F
Drug Metab Rev; 2011 Feb; 43(1):53-68. PubMed ID: 20854129
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.
Xia CQ; Yang JJ; Gan LS
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):595-611. PubMed ID: 16863427
[TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette efflux transporters in human placenta.
Ni Z; Mao Q
Curr Pharm Biotechnol; 2011 Apr; 12(4):674-85. PubMed ID: 21118087
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
8. Role of the breast cancer resistance protein (ABCG2) in drug transport.
Mao Q; Unadkat JD
AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
[TBL] [Abstract][Full Text] [Related]
9. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
10. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
[TBL] [Abstract][Full Text] [Related]
11. Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy.
Szatmári P; Ducza E
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685897
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
[TBL] [Abstract][Full Text] [Related]
13. Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.
Mason CW; Lee GT; Dong Y; Zhou H; He L; Weiner CP
Drug Metab Dispos; 2014 Dec; 42(12):2077-86. PubMed ID: 25261564
[TBL] [Abstract][Full Text] [Related]
14. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
Pollex E; Lubetsky A; Koren G
Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
[TBL] [Abstract][Full Text] [Related]
15. Regional expression of the BCRP/ABCG2 transporter in term human placentas.
Memon N; Bircsak KM; Archer F; Gibson CJ; Ohman-Strickland P; Weinberger BI; Parast MM; Vetrano AM; Aleksunes LM
Reprod Toxicol; 2014 Jan; 43():72-77. PubMed ID: 24269555
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).
Ni Z; Bikadi Z; Rosenberg MF; Mao Q
Curr Drug Metab; 2010 Sep; 11(7):603-17. PubMed ID: 20812902
[TBL] [Abstract][Full Text] [Related]
17. Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth.
Barrett ES; Rivera-Núñez Z; Getz K; Ohman-Strickland P; Zhang R; Kozlosky D; Doherty CL; Buckley BT; Brunner J; Miller RK; O'Connor TG; Aleksunes LM
Environ Res; 2023 May; 225():115597. PubMed ID: 36863650
[TBL] [Abstract][Full Text] [Related]
18. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.
Haimeur A; Conseil G; Deeley RG; Cole SP
Curr Drug Metab; 2004 Feb; 5(1):21-53. PubMed ID: 14965249
[TBL] [Abstract][Full Text] [Related]
19. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
Hutson JR; Koren G; Matthews SG
Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
Pollex EK; Anger G; Hutson J; Koren G; Piquette-Miller M
Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
